Page results
-
At the Cognitive Disorders Clinic, all forms of cognitive disorder are seen; however, we have particular expertise in young onset dementia, familial dementias and unusual degenerative diseases.
-
The National Hospital for Neurology and Neurosurgery (NHNN) has one of the largest, most comprehensive programmes in Europe for the evaluation and medical and surgical treatment of epilepsy.
-
The Neurogenetics Unit offers a fully integrated service encompassing clinical assessment, diagnosis, molecular genetic testing and counselling for neurogenetic conditions.
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
Typically, patient care is multidisciplinary led by consultant neuro-ophthalmologists and neurologists.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
This phlebotomy service is appointment based only (persons who are solely requiring a blood test), including GP patients (Camden & Islington)
-
Diagnostic cytology is a specialist discipline that provides the examination of samples taken by non-invasive or minimally invasive procedures.
-
UCLH has two mortuaries, one at University College Hospital and one at the National Hospital for Neurology and Neurosurgery (NHNN)
-
The day surgery unit, comprises of two operating theatres and a ward located on level T2 at University College Hospital.
File results
-
FOI/2023/0613 - Treatment for Melanoma
-
FOI/2023/0609 - Companies that currently have contracts at UCLH
-
FOI/2023/0604 - Patient flow system
-
FOI/2023/0581 - Treatment of Haemophilia
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0578 - Spinal Muscular Atrophy (SMA) patients
-
FOI/2023/0579 - Procurement for specialist seating for patients
-
FOI/2023/0589 - International nurse recruitment